Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
about
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing associationHidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin diseaseSteroidogenesis in the skin: implications for local immune functionsA Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal MicrobesAcne inversa (Hidradenitis suppurativa): A review with a focus on pathogenesis and treatmentHiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review.Adalimumab in treatment-resistant hidradenitis suppurativa following recurrence after extensive affected area excision: a review of biologics therapy.Hidradenitis suppurativa: the role of immune dysregulation.Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients.A case series of 20 women with hidradenitis suppurativa treated with spironolactone.The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities.The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.Hidradenitis Suppurativa and the Association With Hematological Malignancies.Pre-menstrual flares of pyoderma gangrenosum controlled with use of a combined oral contraceptive and antiandrogen (Ethinyl Estradiol/Drospirenone).Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa.Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease.Axillary hidradenitis.[Acne inversa (hidradenitis suppurativa). From diagnosis to therapy].Considering hidradenitis suppurativa as a bacterial biofilm disease.Power Doppler ultrasound assessment of vascularization in hidradenitis suppurativa lesions.Does obesity cause a distinct phenotype of hidradenitis suppurativa?Identification of HLA-DRB1 association to adalimumab immunogenicity.Hidradenitis suppurativa associated with systemic lupus erythematosus: A case report.Complement Activation in Inflammatory Skin Diseases.
P2860
Q26745455-BE49B89E-D44D-4DC9-8FA6-5A7425A3B4DDQ26828789-37FB1F17-3992-4C08-9788-7BABFD4C87D2Q26830355-03258D49-6BF7-4E1A-8D3C-71BD1D575FDEQ35847339-8EF7E6BE-4B04-4D75-B312-B775FECFC14AQ36612696-67CDA8A1-EDB0-4F9F-96FE-B097EA007A84Q37279315-7E579674-5478-4DDD-8344-79DE52AD62BFQ38056164-CA3ECBAE-0684-48FB-B5DA-E8272452BA13Q38154327-0EBA0170-9C78-4ECB-96F4-7CA2EA742A94Q38222887-0AA8C426-6BB8-4367-AA3B-B077038C00A9Q38393114-61A9EC80-4046-4F10-8D59-3615FE4A7EB1Q38529586-15E372B6-9117-495E-9DF2-686186A3BC7AQ38558963-C8FD8009-42FF-4F7F-9CA7-264DEFBB47CFQ38665824-62862C64-DA86-4A55-937E-44480B64B05FQ40520394-0D6045AA-F4DC-4438-9754-3217E365686CQ40602785-512C15F6-5582-44CB-A6D8-066A200AE525Q40891113-B3154BC3-C56A-413C-BED8-306CBCA386B2Q40966336-5B35F4EE-BC11-45D5-B351-0854ED1F3DEBQ40973597-28648298-8AFB-499A-89EC-ECEF0612AA1FQ42963655-2BA9ECC3-ABA5-4233-A48D-F9F39CCD4772Q43449137-101D7C88-8E8E-4A79-A298-9D8D2D879114Q44881398-471250C4-B94B-416E-A2DF-FFD9C6E89AF6Q47336407-2DF18F27-D141-477C-A891-FACDE1F833BAQ49600767-FB62457E-34E5-4E10-9FC3-E091A004F2D7Q55284744-229AE242-4300-4E7A-84C5-8E1FADF02E88Q55294194-62633A9A-1A34-41D5-B471-57C66F724F0BQ55354503-10EDA20B-CE8D-4D2F-9974-A92D66D33704
P2860
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
@en
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
@nl
type
label
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
@en
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
@nl
prefLabel
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
@en
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
@nl
P2093
P1476
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.
@en
P2093
Gert Folkerts
H H van der Zee
Maiwand Nazary
P356
10.1016/J.EJPHAR.2011.08.047
P407
P577
2011-09-14T00:00:00Z